Tilla S. Worgall, MD, PhD

Pathology - Clinical
Accepting New Patients
Profile Headshot

Profile Navigation

Overview

Email: tpw7@cumc.columbia.edu

Areas of Expertise / Conditions Treated

  • Inborn Error of Metabolism
  • Multiple Myeloma

Academic Appointments

  • Professor of Pathology and Cell Biology at CUMC

Administrative Titles

  • Assistant Director, Special Chemistry

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center

Gender

  • Female

Schedule an Appointment

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Credentials & Experience

Education & Training

  • University of Heidelberg, Faculty of Medicine (Germany)
  • PhD, Heidelberg Medical School, Germany
  • Residency: J Wolfgang Goethe University - Frankfurt
  • Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

Board Certifications

  • Clinical Pathology

Research

Selected Publications

  • Worgall, T.S., Veerappan, A., Sung, B., Kim, B.I., Weiner, E., Bholah, R., Silver, R.B., Jiang, X.C., and Worgall, S.. Impaired sphingolipid synthesis in the respiratory tract induces airway hyperreactivity. Sci Transl Med 2013 5:186ra167
  • Hornemann T, Worgall TS. Sphingolipids and atherosclerosis. Atherosclerosis 2013; 226: 16-28
  • Xu, Y., Krause, A., Limberis, M., Worgall, T.S., and Worgall, S. 2013. Low sphingosine-1-phosphate impairs lung dendritic cells in cystic fibrosis. Am J Respir Cell Mol Biol 2013 48:250-257.
  • Stojanovic, M.N., and Worgall, T.S.. Detecting hydrophobic molecules with nucleic acid-based receptors. Curr Opin Chem Biol, 2010 14:751-757
  • Pei R, Shen Aa, Olah MJ, Stefanovic D, Worgall TS, Stojanovic MN. 2009. High-resolution cross-reactive array for alkaloids. Chem Commun (Camb). 2009 Jun 14;(22):3193-5
  • Chang CL, Seo T, Matsuzaki M, Worgall TS, Deckelbaum RJ. 2009. N-3 fatty acids reduce arterial LDL-cholesterol delivery and arterial lipoprotein lipase levels and lipase distribution. Arterioscler Thromb Vasc Biol. 29: 555-61.
  • Hamai H, Keyserman F, Quittell LM, Worgall TS. 2009. Defective CFTR increases synthesis and mass of sphingolipids that modulate membrane composition and lipid signaling. J Lipid Res. 50: 1101-8.